Insider Transactions in Q1 2021 at Surmodics Inc (SRDX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Open market or private sale
|
Direct |
4,759
-10.02%
|
$266,504
$56.75 P/Share
|
|
Mar 31
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
334
+1.1%
|
$18,704
$56.07 P/Share
|
|
Mar 31
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
318
+1.43%
|
$17,808
$56.07 P/Share
|
|
Mar 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
4,000
-1.19%
|
$208,000
$52.26 P/Share
|
|
Feb 26
2021
|
Susan E Knight |
SELL
Open market or private sale
|
Direct |
5,576
-16.26%
|
$289,952
$52.36 P/Share
|
|
Feb 26
2021
|
Susan E Knight |
BUY
Exercise of conversion of derivative security
|
Direct |
5,576
+13.99%
|
$117,096
$21.31 P/Share
|
|
Feb 26
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
9,139
-16.14%
|
$475,228
$52.15 P/Share
|
|
Feb 26
2021
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Exercise of conversion of derivative security
|
Direct |
13,533
+11.03%
|
$270,660
$20.64 P/Share
|
|
Feb 24
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,444
-11.44%
|
$379,644
$51.7 P/Share
|
|
Feb 24
2021
|
Timothy J. Arens Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,973
+7.89%
|
$219,460
$20.64 P/Share
|
|
Feb 23
2021
|
Jose H Bedoya |
SELL
Open market or private sale
|
Direct |
1,497
-6.16%
|
$74,850
$50.68 P/Share
|
|
Feb 16
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct |
2,500
-2.49%
|
$130,000
$52.0 P/Share
|
|
Feb 12
2021
|
Nusrath Sultana VP, Clinical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-6.4%
|
$23,797
$53.17 P/Share
|
|
Feb 12
2021
|
Ronald B Sr Kalich |
SELL
Payment of exercise price or tax liability
|
Direct |
1,900
-8.08%
|
$100,700
$53.17 P/Share
|
|
Feb 12
2021
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
4,098
+14.85%
|
$106,548
$26.46 P/Share
|
|
Feb 11
2021
|
Jose H Bedoya |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+4.2%
|
-
|
|
Feb 11
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+3.46%
|
-
|
|
Feb 11
2021
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+11.4%
|
-
|
|
Feb 11
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+5.21%
|
-
|
|
Feb 11
2021
|
Susan E Knight |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+3.85%
|
-
|
|
Feb 11
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,152
-25.02%
|
$2,976,056
$53.86 P/Share
|
|
Feb 11
2021
|
Gary R Maharaj President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
82,264
+12.04%
|
$1,727,544
$21.74 P/Share
|
|
Feb 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
3,000
-1.03%
|
$135,000
$45.16 P/Share
|
|
Jan 05
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct |
2,500
-4.71%
|
$112,500
$45.0 P/Share
|
|
Jan 04
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.36%
|
$86,000
$43.96 P/Share
|